Health Sciences Acquisitions Corporation 2

HSAQ · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$20,828-$19,363-$18,755-$50,084
Dep. & Amort.$81$81$83$237
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,013$3,250$2,965$9,126
Change in WC$632$0$0$1,731
Other Non-Cash$2,552$505-$909$2,813
Operating Cash Flow-$14,550-$15,527-$16,616-$36,177
Investing Activities
PP&E Inv.-$310-$34-$112-$254
Net Acquisitions$0$0$0-$602
Inv. Purchases-$47,781$0-$2,902-$29,154
Inv. Sales/Matur.$9,507$16,390$16,013$86,628
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$38,584$16,356$12,999$56,618
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$57,689$0$0$352
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$76,397-$428-$296-$27,650
Financing Cash Flow$76,397-$428-$296-$27,650
Forex Effect$0$0$0$0
Net Chg. in Cash$23,263$401-$3,913$0
Supplemental Information
Beg. Cash$18,749$18,348$22,261$25,605
End Cash$42,012$18,749$18,348$22,261
Free Cash Flow-$14,860-$15,561-$16,728-$36,431
Health Sciences Acquisitions Corporation 2 (HSAQ) Financial Statements & Key Stats | AlphaPilot